Application Sponsors
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
Application Products
001 | TABLET; ORAL | 50MG; 500MG | 0 | SITAGLIPTIN; METFORMIN HYDROCHLORIDE | SITAGLIPTIN; METFORMIN HYDROCHLORIDE |
002 | TABLET; ORAL | 50MG; 1000MG | 0 | SITAGLIPTIN; METFORMIN HYDROCHLORIDE | SITAGLIPTIN; METFORMIN HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2014-03-10 | |
Submissions Property Types
CDER Filings
APOTEX INC
cder:Array
(
[0] => Array
(
[ApplNo] => 202426
[companyName] => APOTEX INC
[docInserts] => ["",""]
[products] => [{"drugName":"SITAGLIPTIN; METFORMIN HYDROCHLORIDE","activeIngredients":"SITAGLIPTIN; METFORMIN HYDROCHLORIDE","strength":"50MG; 500MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"SITAGLIPTIN; METFORMIN HYDROCHLORIDE","activeIngredients":"SITAGLIPTIN; METFORMIN HYDROCHLORIDE","strength":"50MG; 1000MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"03\/10\/2014","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2014-03-10
)
)